Haitao Pan, Associate Professor at St. Jude Children’s Research Hospital, shared on LinkedIn:
“I’m pleased to share that I have joined the Editorial Board of JCO Precision Oncology, an American Society of Clinical Oncology (ASCO) journal, for the 2027–2029 term.
My work sits at the intersection of biostatistics, clinical trial design, and pediatric oncology.
I am also increasingly exploring how AI-enabled workflows can strengthen the generation, evaluation, and use of credible clinical evidence.
I look forward to contributing to rigorous peer review and advancing evidence-based decision-making in precision oncology.
My thanks to Dr Zsofia K. Stadler and the editorial team for the opportunity.”
Other articles about precision oncology on OncoDaily.